Overview

A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Composite corneal staining score of greater than 5 in one or both eyes.

- Schirmer II score of greater than 4 mm.

- OSDI score of greater than 23.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Any medical condition (systemic or ophthalmic) that may, in the opinion of the
investigator, preclude the safe administration of the test article or safe
participation in this study.

- Other protocol-defined exclusion criteria may apply.